Cartesian Therapeutics, Descartes-08, Lancet, myasthenia gravis
Rare autoimmune disorder myasthenia gravis treated by CAR-T therapy
July 2023: Evidence from a small-scale clinical trial shows that myasthenia gravis, an autoimmune disorder of the nervous system, could be treated with a variation of CAR-T, an advanced blood cancer immunotherapy. The modifie..
Lancet, Mekinist, Tamoxifen, Trametinib
New treatment identified for low grade and serous ovarian cancer
May 2022: Trametinib may become a new standard of care for recurring, low-grade serous ovarian cancer (Mekinist). According to study findings published in the February 2022 issue of The Lancet, trametinib beat both chemotherapy an..